BMO Capital Cuts Price Target on Comtech Telecom (CMTL) to $16 Following 1Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Pre-Open Stock Movers 12/08: (VYGR) (TLRD) (LULU) Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
December 8, 2016 9:29 AM EST(Updated - December 8, 2016 9:30 AM EST)
Today's Pre-Open Stock Movers:
Voyager Therapeutics, Inc. (Nasdaq: VYGR) 38.2% HIGHER; announced positive results from the ongoing Phase 1b trial of VY-AADC01 at six and twelve months of follow-up in patients with advanced Parkinsons disease. The interim data from Cohorts 1 and 2 of this trial demonstrated that accurate MRI-guided delivery of escalating doses of VY-AADC01 were well tolerated and resulted in increased coverage of the putamen, increased AADC enzyme activity, enhanced response to levodopa, and dose-related, clinically meaningful improvements in various... More
After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
December 7, 2016 7:04 PM ESTToday's After-Hours Movers:
Voyager Therapeutics, Inc. (Nasdaq: VYGR) 35.2% HIGHER; announced positive results from the ongoing Phase 1b trial of VY-AADC01 at six and twelve months of follow-up in patients with advanced Parkinsons disease. The interim data from Cohorts 1 and 2 of this trial demonstrated that accurate MRI-guided delivery of escalating doses of VY-AADC01 were well tolerated and resulted in increased coverage of the putamen, increased AADC enzyme activity, enhanced response to levodopa, and dose-related, clinically meaningful improvements in various measures of patients motor function. This was... More
Comtech Telecom (CMTL) Slashes Quarterly Dividend 66.7% to $0.10; 3.1% Yield
December 7, 2016 4:21 PM ESTComtech Telecom (NASDAQ: CMTL) declared a quarterly dividend of $0.10 per share, or $0.4 annualized. This is a 66.7% decrease from the prior dividend of $0.30.
The dividend will be payable on February 17, 2017, to stockholders of record on January 18, 2017, with an ex-dividend date of January 13,... More
Comtech Telecom (CMTL) Tops Q1 EPS by 5c
December 7, 2016 4:20 PM ESTComtech Telecom (NASDAQ: CMTL) reported Q1 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $135.8 million versus the consensus estimate of $139.1 million.
GUIDANCE:
Comtech Telecom sees FY2017 EPS of $0.30, versus the consensus of $0.29. Comtech... More
Trading Radar for 12/7: lululemon (LULU), SecureWorks (SCWX), Vera Bradley (VRA), Tailored Brands (TLRD) Report
December 6, 2016 1:55 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
Brown-Forman (NYSE: BF-B) - consensus EPS $0.50
Hooker Furniture (Nasdaq: HOFT) - consensus EPS $0.46
John... More

